Description

5,11-Methanofuro[3,4-d][3]benzoxonin-1,12(3H,5H)-dione, 6,6a,7,8,9,10,10a,11-octahydro-6,6a-dihydroxy-3,11,13-trimethyl-, [3S-(3R*,5R*,6S*,6aR*,10aR*,11S*,13R*)]- (9CI) is a complex, stereochemically defined organic compound of significant interest in advanced chemical synthesis. Its intricate fused-ring structure makes it a valuable advanced intermediate or building block for pharmaceutical research and fine chemical development. This compound is primarily utilized by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and specialty chemical industries for creating novel molecular entities.

Application

• Pharmaceutical Intermediate: Serves as a key chiral building block in the synthesis of complex drug candidates, particularly those targeting central nervous system or anti-inflammatory pathways.
• Agrochemical Research: Used in the development of novel active ingredients with specific stereochemical requirements for enhanced efficacy.
• Chemical Biology Probe: Acts as a scaffold or precursor for designing molecular probes to study enzyme mechanisms or biological pathways.
• Asymmetric Synthesis: Employed as a starting material or intermediate in stereoselective synthesis due to its multiple defined chiral centers.
• Material Science Research: Potential precursor for specialized polymers or organic electronic materials requiring rigid, fused-ring structures.

Basic Information

Product Name	5,11-Methanofuro[3,4-d][3]benzoxonin-1,12(3H,5H)-dione, 6,6a,7,8,9,10,10a,11-octahydro-6,6a-dihydroxy-3,11,13-trimethyl-, [3S-(3R*,5R*,6S*,6aR*,10aR*,11S*,13R*)]- (9CI)
CAS No.	166403-10-7
Molecular Formula	C19H24O6
Molecular Weight	348.39 g/mol
Synonyms	(3R,5R,6S,6aR,10aR,11S,13R)-6,6a-Dihydroxy-3,11,13-trimethyl-1,3,4,5,6,6a,7,8,9,10,10a,11,12,13-tetradecahydro-5,11-methanofuro[3,4-d][3]benzoxonine-1,12-dione; 5,11-Methanofuro[3,4-d][3]benzoxonin-1,12-dione, octahydro-6,6a-dihydroxy-3,11,13-trimethyl-, (3S-(3R*,5R*,6S*,6aR*,10aR*,11S*,13R*))-; 9CI-166403-10-7; A complex methanofurobenzoxonine derivative.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality control protocols to ensure batch-to-batch consistency and high purity, critical for sensitive R&D and scale-up processes. Quality is verified through comprehensive analytical techniques including HPLC, chiral analysis, NMR, and mass spectrometry. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting identity, purity, and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture uptake, which may affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Chiral Purity	≥ 98.0% ee
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.